{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:02:38Z","timestamp":1791295358918,"version":"4.1.0"},"reference-count":44,"publisher":"Impact Journals, LLC","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2013,11,30]]},"DOI":"10.18632\/oncotarget.1534","type":"journal-article","created":{"date-parts":[[2015,9,16]],"date-time":"2015-09-16T21:45:41Z","timestamp":1442439941000},"page":"2080-2095","source":"Crossref","is-referenced-by-count":138,"title":["BET bromodomain protein inhibition is a therapeutic option for medulloblastoma"],"prefix":"10.18632","volume":"4","author":[{"given":"Anton","family":"Henssen","sequence":"first","affiliation":[{"name":"Department of Pediatric Oncology and Hematology, University Children's Hospital Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Thor","sequence":"additional","affiliation":[{"name":"German Cancer Consortium (DKTK), Germany"},{"name":"German Cancer Research Center (DKFZ), Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Odersky","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology and Hematology, University Children's Hospital Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Heukamp","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolai","family":"El-Hindy","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneleen","family":"Beckers","sequence":"additional","affiliation":[{"name":"Center of Medical Genetics Ghent (CMGG), Ghent University Hospital, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Speleman","sequence":"additional","affiliation":[{"name":"Center of Medical Genetics Ghent (CMGG), Ghent University Hospital, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Althoff","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology and Hematology, University Children's Hospital Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Sch\u00e4fers","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology and Hematology, University Children's Hospital Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Schramm","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology and Hematology, University Children's Hospital Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Sure","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudrun","family":"Fleischhack","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology and Hematology, University Children's Hospital Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Eggert","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology\/Hematology, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes H.","family":"Schulte","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology and Hematology, University Children's Hospital Essen, Essen, Germany"},{"name":"Centre for Medical Biotechnology, University Duisburg-Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2013,10,27]]},"reference":[{"issue":"9","key":"1","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrclinonc.2011.95","article-title":"Challenging issues in pediatric oncology","volume":"8","author":"Medscape","year":"2011","journal-title":"Nature reviews Clinical oncology"},{"issue":"3","key":"2","first-page":"190","article-title":"Incidence and trends in pediatric malignancies medulloblastoma\/primitive neuroectodermal tumor: a SEER update","volume":"39","author":"Rorke","year":"2002","journal-title":"Surveillance Epidemiology and End Results. Medical and pediatric oncology"},{"issue":"4","key":"3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00401-011-0922-z","article-title":"Molecular subgroups of medulloblastoma: the current consensus","volume":"123","author":"Pfister","year":"2012","journal-title":"Acta neuropathologica"},{"issue":"11","key":"4","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1200\/JCO.2010.28.5148","article-title":"Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome","volume":"29","author":"Kool","year":"2011","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"issue":"11","key":"5","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1200\/JCO.2009.27.4324","article-title":"Medulloblastoma comprises four distinct molecular variants","volume":"29","author":"Taylor","year":"2011","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"issue":"19","key":"6","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1200\/JCO.2011.34.9373","article-title":"Adult medulloblastoma comprises three major molecular variants","volume":"29","author":"Korshunov","year":"2011","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"issue":"11","key":"7","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1200\/JCO.2010.30.2810","article-title":"Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables","volume":"29","author":"Clifford","year":"2011","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"issue":"10","key":"8","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1200\/JCO.2008.17.9432","article-title":"Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci","volume":"27","author":"Scheurlen","year":"2009","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"issue":"6765","key":"9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/47412","article-title":"The language of covalent histone modifications","volume":"403","author":"Allis","year":"2000","journal-title":"Nature"},{"issue":"4","key":"10","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.bjc.6601575","article-title":"Linking the epigenetic \u2018language\u2019 of covalent histone modifications to cancer","volume":"90","author":"Allis","year":"2004","journal-title":"British journal of cancer"},{"issue":"18","key":"11","doi-asserted-by":"crossref","first-page":"13141","DOI":"10.1074\/jbc.R700001200","article-title":"The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation","volume":"282","author":"Chiang","year":"2007","journal-title":"The Journal of biological chemistry"},{"key":"12","first-page":"D1008","article-title":"You bet-cha: a novel family of transcriptional regulators","volume":"6","author":"Faller","year":"2001","journal-title":"Frontiers in bioscience : a journal and virtual library"},{"issue":"3","key":"13","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1006\/geno.1997.5000","article-title":"Identification and characterization of BRDT: A testis-specific gene related to the bromodomain genes RING3 and Drosophila fsh","volume":"45","author":"Shimane","year":"1997","journal-title":"Genomics"},{"issue":"1","key":"14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.molcel.2008.01.018","article-title":"The double bromodomain proteins Brd2 and Brd3 couple histone acetylation to transcription","volume":"30","author":"Flint","year":"2008","journal-title":"Molecular cell"},{"issue":"20","key":"15","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1101\/gad.1235904","article-title":"Elongation by RNA polymerase II: the short and long of it","volume":"18","author":"Reinberg","year":"2004","journal-title":"Genes & development"},{"issue":"3","key":"16","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1128\/MCB.01020-07","article-title":"Brd4 recruits P-TEFb to chromosomes at late mitosis to promote G1 gene expression and cell cycle progression","volume":"28","author":"Zhou","year":"2008","journal-title":"Molecular and cellular biology"},{"issue":"23","key":"17","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.1091\/mbc.e09-05-0380","article-title":"Brd4 marks select genes on mitotic chromatin and directs postmitotic transcription","volume":"20","author":"Ozato","year":"2009","journal-title":"Molecular biology of the cell"},{"issue":"16","key":"18","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.4161\/cc.6.16.4554","article-title":"P-TEFb is a crucial co-factor for Myc transactivation","volume":"6","author":"Lania","year":"2007","journal-title":"Cell cycle"},{"issue":"13B","key":"19","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1002\/j.1460-2075.1985.tb04142.x","article-title":"Phosphorylation and activation of hamster carbamyl phosphate synthetase II by cAMP-dependent protein kinase. A novel mechanism for regulation of pyrimidine nucleotide biosynthesis","volume":"4","author":"Hardie","year":"1985","journal-title":"The EMBO journal"},{"issue":"6","key":"20","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","article-title":"BET bromodomain inhibition as a therapeutic strategy to target c-Myc","volume":"146","author":"Bergsagel","year":"2011","journal-title":"Cell"},{"issue":"40","key":"21","doi-asserted-by":"crossref","first-page":"16669","DOI":"10.1073\/pnas.1108190108","article-title":"Targeting MYC dependence in cancer by inhibiting BET bromodomains","volume":"108","author":"Sims","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"11","key":"22","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/ng.2436","article-title":"LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression","volume":"44","author":"Sprussel","year":"2012","journal-title":"Nature genetics"},{"issue":"7327","key":"23","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature09504","article-title":"Selective inhibition of BET bromodomains","volume":"468","author":"West","year":"2010","journal-title":"Nature"},{"issue":"7409","key":"24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature11213","article-title":"Novel mutations target distinct subgroups of medulloblastoma","volume":"488","author":"Thiruvenkatam","year":"2012","journal-title":"Nature"},{"issue":"4","key":"25","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/j.1460-2075.1990.tb08217.x","article-title":"Negative autoregulation of c-myc transcription","volume":"9","author":"Land","year":"1990","journal-title":"The EMBO journal"},{"issue":"24","key":"26","doi-asserted-by":"crossref","first-page":"9545","DOI":"10.1073\/pnas.1121119109","article-title":"Functional genomics identifies therapeutic targets for MYC-driven cancer","volume":"109","author":"Grandori","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"27","article-title":"Inhibition of BET Bromodomain Targets Genetically Diverse Glioblastoma","author":"Wang","year":"2013","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"issue":"3","key":"28","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1158\/2159-8290.CD-12-0418","article-title":"Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition","volume":"3","author":"Bradner","year":"2013","journal-title":"Cancer discovery"},{"key":"29","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1471-2407-11-74","article-title":"c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patients","volume":"11","author":"Grotzer","year":"2011","journal-title":"BMC cancer"},{"issue":"2","key":"30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1215\/15228517-1-2-139","article-title":"Cytogenetics and molecular genetics of childhood brain tumors","volume":"1","author":"Biegel","year":"1999","journal-title":"Neuro-oncology"},{"issue":"2","key":"31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/neuonc\/4.2.115","article-title":"MDM2 overexpression is associated with short survival in adults with medulloblastoma","volume":"4","author":"Chio","year":"2002","journal-title":"Neuro-oncology"},{"issue":"7","key":"32","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/neuonc\/nos115","article-title":"Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomas","volume":"14","author":"Schulte","year":"2012","journal-title":"Neuro-oncology"},{"issue":"4","key":"33","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ccr.2012.09.015","article-title":"The requirement for cyclin D function in tumor maintenance","volume":"22","author":"Sicinski","year":"2012","journal-title":"Cancer cell"},{"issue":"3","key":"34","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11060-012-0978-1","article-title":"HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatment","volume":"110","author":"Deubzer","year":"2012","journal-title":"Journal of neuro-oncology"},{"key":"35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-407676-1.00001-9","article-title":"The repair and signaling responses to DNA double-strand breaks","volume":"82","author":"Jeggo","year":"2013","journal-title":"Advances in genetics"},{"issue":"3","key":"36","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.tig.2011.12.002","article-title":"The p53 network: cellular and systemic DNA damage responses in aging and cancer","volume":"28","author":"Schumacher","year":"2012","journal-title":"Trends in genetics : TIG"},{"issue":"7453","key":"37","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nature12147","article-title":"The bromodomain protein Brd4 insulates chromatin from DNA damage signalling","volume":"498","author":"Del Rosario","year":"2013","journal-title":"Nature"},{"issue":"9","key":"38","doi-asserted-by":"crossref","first-page":"e24584","DOI":"10.1371\/journal.pone.0024584","article-title":"MiR-34a targeting of Notch ligand delta-like 1 impairs CD15+\/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastoma","volume":"6","author":"Schulte","year":"2011","journal-title":"PloS one"},{"issue":"7","key":"39","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"Speleman","year":"2002","journal-title":"Genome biology"},{"issue":"19","key":"40","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1038\/onc.2009.70","article-title":"Galectin-1 is a major effector of TrkB-mediated neuroblastoma aggressiveness","volume":"28","author":"Schramm","year":"2009","journal-title":"Oncogene"},{"issue":"141","key":"41","first-page":"141","article-title":"Targeted expression of mutated ALK induces neuroblastoma in transgenic mice","volume":"4","author":"Konig","year":"2012","journal-title":"Science translational medicine"},{"issue":"10","key":"42","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/gb-2004-5-10-r80","article-title":"Bioconductor: open software development for computational biology and bioinformatics","volume":"5","author":"Leisch","year":"2004","journal-title":"Genome biology"},{"issue":"22","key":"43","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1093\/bioinformatics\/btl476","article-title":"RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis","volume":"22","author":"Chory","year":"2006","journal-title":"Bioinformatics"},{"issue":"43","key":"44","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Mesirov","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.1534","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T14:15:20Z","timestamp":1594822520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.1534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,27]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11,30]]}},"alternative-id":["1534","24231268"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.1534","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,27]]}}}